Michelle A. Farrar
New South Wales Department of Health(AU)UNSW Sydney(AU)Sydney Children's Hospital(AU)Sydney Children’s Hospitals Network(AU)Neuroscience Research Australia(AU)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, RNA modifications and cancer, Congenital Anomalies and Fetal Surgery, Muscle Physiology and Disorders, Family and Disability Support Research
Most-Cited Works
- → Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial(2022)275 cited
- → Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial(2022)260 cited
- → Emerging therapies and challenges in spinal muscular atrophy(2016)257 cited
- → Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series(2020)189 cited
- → Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go(2021)167 cited
- → The implementation of newborn screening for spinal muscular atrophy: the Australian experience(2019)164 cited